More on JANX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+100.0% Growth)
- Ratings (8.4 Score)

Upcoming Events

- Earnings (8/12/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Janux Therapeutics (NQ:JANX)
Delayed: 13.84 -0.13 (0.93%)
Prev. Close $13.97  
Open$13.67 
52 Wk High$0.01 
52 Wk Low$0.00 
Day High$13.96 
Day Low$13.50 
P/E N/A  
EPS$0.00 
Volume802,231 

Friends, Peers and Foes (?): MRUS, SMMT, BNTX, CNTX, MGNX (more...)

Mar 3, 2026 07:17 AM Janux Therapeutics (JANX) PT Lowered to $80 at Truist Securities
Feb 27, 2026 08:33 AM Janux Therapeutics (JANX) PT Lowered to $100 at Cantor Fitzgerald
Feb 27, 2026 06:47 AM Janux Therapeutics (JANX) PT Lowered to $68 at Guggenheim
Feb 26, 2026 05:20 PM Janux Therapeutics, Inc. (JANX) Tops Q4 EPS by 11c
Feb 26, 2026 04:52 PM Form S-8 Janux Therapeutics, Inc.
Feb 26, 2026 04:39 PM Form 10-K Janux Therapeutics, Inc. For: Dec 31
Feb 26, 2026 04:15 PM Form 8-K Janux Therapeutics, Inc. For: Feb 26
Feb 26, 2026 04:01 PM Janux Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
Feb 17, 2026 04:36 PM Form SCHEDULE 13G/A Janux Therapeutics, Inc. Filed by: JANUS HENDERSON GROUP PLC
Feb 17, 2026 07:00 AM Janux Therapeutics doses first patient in JANX011 phase 1 trial
View All Articles

Entities mentioned with JANX

View All Entities